Canndoc enters long-term agreement with Super-Pharm

Posted by - March 10, 2020

Israel-based Super-Pharm is going to be on the hook for huge purchases of Canndoc products Partnerships among cannabis industries and traditional companies are becoming a trend and a case point is made with this recent agreement signed between Intercure’s wholly owned subsidiary, Canndoc, and the largest drugstore chain in Israel. Super-Pharm will, under the terms

Curaleaf makes changes to shares agreement as it looks to acquire Cura Partners

Posted by - January 24, 2020

The shift is designed to make the acquisition more equitable for all shareholders In a deal in which Curaleaf absorbed Cura Partners, the original agreement was to hold a percentage of the shares, initially estimated at 15%, that was outstanding following the acquisition in one of the now more common lock-up agreements. This past Wednesday,